InsidersTradesSigma
Track the PARADIGM BIOPHARMACEUTICALS LIMITED.. share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €104.9m. The latest transaction was disclosed on 18 June 2026 (Other). Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
PARADIGM BIOPHARMACEUTICALS LIMITED is an Australian Securities Exchange listed company focused on developing treatments for chronic diseases and musculoskeletal disorders. It specializes in regenerative medicine and stem cell-based therapies.